Reliability of Kinovea in Gait Assessment in Multiple Sclerosis: a Pilot Study.

NCT06928194 | Completed

• 1 other identifier: SICEIA-2025-000557
• Study Type: observational
• Target: 24
• Locations: 1 country
• Sites: 1

Brief Summary

The objective of this observational study is to determine whether the Kinovea video analysis tool is valid and reliable for analyzing spatiotemporal gait parameters in multiple sclerosis, comparing the data obtained from this system with those of the gold standard, the GaitRite system. The main question to be answered is: Is the Kinovea system valid and reliable for analyzing spatiotemporal gait parameters in multiple sclerosis? Participants walked across the GAITRite platform four times without shoes and four times with shoes, while being recorded by two cameras simultaneously: one recorded gait from the sagittal plane and the other from the frontal plane.

Conditions

Multiple Sclerosis; Gait Disorders, Neurologic

Keywords

Multiple Sclerosis; Gait Disorders, Neurologic; Kinovea; GAITRite

Outcome Measures

Primary Outcomes (5)

• Step length (cm)

  Distance between the two heel strike points during initial contact of opposing feet.

  With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.

• Stride length (cm)

  Distance between the two heel strike points during initial contact of the same foot. Two step lengths add up to one stride length.

  With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.

• Support base (cm)

  Distance between the midpoints of the heels of two consecutive steps

  With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.

• Cadence (steps/min)

  Number of steps taken during a given period

  With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.

• Walking speed (cm/s)

  Time taken to walk a known distance

  With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.

Eligibility Criteria

• Age: 18 Years - 55 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Young-to-middle-aged people with multiple sclerosis who maintain the ability to walk and who come to the laboratory for their scheduled checkups.

You may qualify if:

• Patients scheduled for evaluation by the NeuroLab-Lázaro gait laboratory (Seville).
• Patients who have signed informed consent prior to the test.
• Patients between 18 and 55 years of age, diagnosed with MS according to the 2017 McDonald criteria.
• Patients with an EDSS score of less than 6.5 points.
• Patients who are willing to participate in the study and who do not object to being recorded while performing the gait test and to the use of images for educational and research purposes.

You may not qualify if:

• Patients who use walking aids and/or orthoses.
• Patients with comorbidity or decompensated systemic disease within the last month.
• Patients who have any physical impediment (excessive fatigue) to performing the gait test, as documented in their medical records reviewed on the Diraya platform.
• Patients who have suffered a relapse within 30 days prior to the start of the study.

Sponsors & Collaborators

• University of Cadiz: lead
• Hospital Universitario Virgen Macarena: collaborator

Study Sites (1)

NeuroLab-Lázaro

Seville, Sevilla, 41015, Spain

Location

MeSH Terms

Conditions

Multiple Sclerosis; Gait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNS; Autoimmune Diseases of the Nervous System; Nervous System Diseases; Demyelinating Diseases; Autoimmune Diseases; Immune System Diseases; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Carlos Luque Moreno

  University of Seville

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Physiotherapist, student of a master's degree in Neurological Physiotherapy

Study Record Dates

• First Submitted: April 7, 2025
• First Posted: April 15, 2025
• Study Start: March 10, 2025
• Primary Completion: April 2, 2025
• Study Completion: April 2, 2025
• Last Updated: April 18, 2025

Record last verified: 2025-04

Locations

ES (1)